David Darling - Pacific Edge CEO and Executive Director

PEB -- New Zealand Stock  

NZD 0.34  0.005  1.47%

  CEO
Mr. David Gregory Darling is Chief Executive Officer, Executive Director of Pacific Edge Limited. Dave has over 30 years business experience in life sciences and biotechnology. He has led Pacific Edge from its early inception and has significant executive and leadership experience in the development and international commercialization of biomedical and biotechnology businesses and products. During his career, Dave has held a number of positions in governance, executive and senior management. Dave joined Pacific Edge from Fletcher Challenge.
  CEO Since 2014      
64 3 479 5800  http://www.pacificedge.co.nz

Management Efficiency

The company has return on total asset (ROA) of (66.91) % which means that it has lost $66.91 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (124.28) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 99K in total debt with debt to equity ratio (D/E) of 0.6 which is about average as compared to similar companies. Pacific Edge Limited has Current Ratio of 6.06 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 6 records

CEO Since

Patrick DaviesEBOS Group Limited
N/A
MAgribus BBusArvida Group Limited
N/A
Michael DaniellFisher Paykel Healthcare Corpor
2016
Bill McDonaldArvida Group Limited
2014
Brett HewlettComvita Limited
2017
Scott CoulterComvita Limited
2015

Entity Summary

Pacific Edge Limited, a cancer diagnostic company, develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand and internationally. Pacific Edge Limited was founded in 2001 and is headquartered in Dunedin, New Zealand. Pacific Edge operates under Diagnostics Research classification in New Zealand and is traded on New Zealand Stock Exchange.Pacific Edge Limited (PEB) is traded on New Zealand Stock Exchange in New Zealand. It is located in Centre for Innovation and employs 2 people.

Pacific Edge Limited Leadership Team

Chris Gallaher, Independent Director
Parry Guilford, Chief Scientific Officer and Member of Scientific Advisory Board
Kate Rankin, CFO
N Kasabov, Head of Knowledge Engineering Discovery Research Institute (KEDRI)
Jimmy Suttie, COO
Christopher Swann, Chairman of the Board
David Darling, CEO and Executive Director
David Band, Independent Director
David Levison, Director
Charles Sitch, Independent Director
Brent Pownall, Commercial Director of Pacific Edge Diagnostics - New Zealand
Jackie Walker, CEO - Pacific Edge Diagnostics USA Ltd (PEDUSA)
Anatole Masfen, Director
Nikola Kasabov, Head of Knowledge Engineering Discovery Research Institute (KEDRI)
Bryan Williams, Independent Director

Stock Performance Indicators

Current Sentiment - PEB

Pacific Edge Limited Investor Sentiment

Most of Macroaxis users are at this time bullish on Pacific Edge Limited. What is your perspective on investing in Pacific Edge Limited? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
CTL   
Purchased over 90 shares of
3 hours ago
Traded for 16.27
NLY   
Purchased over 90 shares of
3 hours ago
Traded for 10.07
CRM   
Purchased over 100 shares of
3 hours ago
Traded for 137.04
V   
Purchased over 100 shares of
3 hours ago
Traded for 132.67
MSFT   
Purchased over 100 shares of
3 hours ago
Traded for 103.3
Additionally take a look at Your Equity Center. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com